[HTML][HTML] Advances in the Bioactivities of Phytochemical Saponins in the Prevention and Treatment of Atherosclerosis

H Luo, J Chen, C Su, L Zha - Nutrients, 2022 - mdpi.com
Atherosclerosis (AS) is a chronic inflammatory disease characterized by hardening and
narrowing of arteries. AS leads to a number of arteriosclerotic vascular diseases including …

Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced …

F Xiong, Z Zheng, L Xiao, C Su, J Chen… - Molecular Nutrition & …, 2021 - Wiley Online Library
Scope Nonalcoholic steatohepatitis (NASH) is a chronic progressive disease with complex
pathogenesis of which the bile acids (BAs) and gut microbiota are involved. Soyasaponins (…

Milk Exosomes from Gestational Diabetes Mellitus (GDM) and Healthy Parturient Exhibit Differential miRNAs Profiles and Distinct Regulatory Bioactivity on Hepatocyte …

…, J Wang, J Chen, H Luo, Y Liu, C Su… - Molecular Nutrition & …, 2023 - Wiley Online Library
Scope Exosomes, a novel type of bioactive component in human milk (HM), affect infant
development, growth, and health. Recent studies indicate that HM exosomes and miRNAs relate …

[HTML][HTML] Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts

J Chen, H Ullah, Z Zheng, X Gu, C Su, L Xiao… - … Medicine and Therapies, 2020 - Springer
Background Previous studies indicate that soyasaponins may reduce inflammation via
modulating toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88) signaling. …

Soyasaponins A 1 and A 2 exert anti-atherosclerotic functionalities by decreasing hypercholesterolemia and inflammation in high fat diet (HFD)-fed ApoE−/− mice

Q Xie, F Xiong, X Wu, J Chen, X Gu, C Su, L Xiao… - Food & function, 2020 - pubs.rsc.org
Atherosclerosis is a chronic inflammatory disease causing coronary heart attacks and strokes.
Soyasaponins (SS), the phytochemicals naturally existing in soybeans and their products, …

[HTML][HTML] Inflammation induced by lipopolysaccharide and palmitic acid increases cholesterol accumulation via enhancing myeloid differentiation factor 88 expression …

…, Z Zheng, T Wang, X Hu, Y Zhao, J Tang, C Su… - Pharmaceuticals, 2022 - mdpi.com
Recently, multiple studies have shown that chronic inflammation disturbs cholesterol
homeostasis and promotes its accumulation in the liver. The underlying molecular mechanism …

Gut Microbiota Plays Essential Roles in Soyasaponin's Preventive Bioactivities against Steatohepatitis in the Methionine and Choline Deficient (MCD) Diet‐Induced …

C Su, J Wang, H Luo, J Chen, F Lin… - Molecular Nutrition & …, 2024 - Wiley Online Library
Scope Gut microbiota (GM) is involved in nonalcoholic steatohepatitis (NASH) development.
Phytochemicals soyasaponins can prevent NASH possibly by modulating GM. This study …

Xylooligosaccharides ameliorate insulin resistance by increasing Akkermansia muciniphila and improving intestinal barrier dysfunction in gestational diabetes mellitus …

J Yang, J Wang, W Wu, C Su, Y Wu, Q Li - Food & Function, 2024 - pubs.rsc.org
Little is known regarding the effects of xylooligosaccharides (XOS) on insulin resistance (IR)
in gestational diabetes mellitus (GDM). We aimed to investigate this issue and its …

[HTML][HTML] Soyasaponin A1 inhibits the lipid raft recruitment and dimerization of TLR4, MyD88, and TRIF by maintaining cholesterol homeostasis in palmitic acid …

X Gu, J Tang, Y Zhao, C Su, L Xiao, H Luo, Y Liu… - Journal of Functional …, 2021 - Elsevier
The mechanisms of soyasaponin A 1 (SS-A 1 ) on antagonizing inflammation via regulating
the lipid raft-mediated toll-like receptor 4 (TLR4) signaling are not completely understood. In …

[HTML][HTML] The Accelerated Progression of Atherosclerosis Correlates with Decreased miR-33a and miR-21 and Increased miR-122 and miR-3064-5p in Circulation and …

…, JB Chen, XF Gu, JQ Tang, Y Zhao, CH Su… - Current Issues in …, 2022 - mdpi.com
Atherosclerosis is a major risk factor for type 2 diabetes (T2D) mortality. We aim to investigate
the changes in miR-21, miR-122, miR-33a and miR-3064-5p in circulation and the liver of …